Skip to main content Accessibility help
×
Home
Hostname: page-component-5c569c448b-t6r6x Total loading time: 0.274 Render date: 2022-07-02T04:27:28.968Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "useNewApi": true } hasContentIssue true

The Influence of Cardiazol on Chronic Schizophrenia

Published online by Cambridge University Press:  08 February 2018

A. J. Bain*
Affiliation:
City Mental Hospital, Leicester

Extract

A small controlled series of cases of schizophrenia was treated with cardiazol at this hospital. A list of all those thought suitable for treatment was drawn up in order of date of admission and divided into two by selecting alternate cases. From the prognostic point of view there was little to choose between the two groups. The average duration of illness for all patients was six years. At the Berne-Munsingen Congress it was agreed that the remission rate falls rapidly with the duration of the illness, and that few cases of over four years' duration recovered with cardiazol treatment. This is also the opinion of others (1), (2), (3), (4), (5), (6), (7), (8), so no startling results were anticipated.

Type
Part I.—Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1940 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Harris, A. (1938), “Cardiazol Treatment of Schizophrenia,” Journ. Ment. Sci., 84, 735.CrossRefGoogle Scholar
2 Kennedy, A. (1937), “Convulsion Therapy in Schizophrenia,” ibid., 83, 609.Google Scholar
3 Nightingale, G. S. (1938), “Six Months' Experience with Cardiazol Therapy,” ibid., 84, 574.Google Scholar
4 Ross, Jno. R. (1939), “The Pharmacological Shock Treatment of Schizophrenia,” Amer. Journ. Psychiat., 95, 769.CrossRefGoogle Scholar
5 Read, C. R., Steinberg, L., Liebert, E., and Finkelman, I. (1939), “Use of Metrazol in the Functional Psychoses,” ibid., 95, 781.Google Scholar
6 Williams, G. H., Williams, G. H. jun., Kingsbury, H. M., and Bixby, D. E. (1939), “Experiences with the Pharmacological Shock Treatment of Schizophrenia,” ibid., 95, 811.Google Scholar
7 Briner, O. (1938), “Results of the Convulsion Therapy in the Psychiatric Clinic in Berne,” ibid., 94, 167.Google Scholar
8 Finkelman, I., Steinberg, D. L., and Liebert, E. (1938), “The Treatment of Schizophrenia with Metrazol by Production of Convulsions,” Journ. Amer. Med. Assoc., 110, 706.CrossRefGoogle Scholar
9 Stalker, H. (1939), “Prognosis in Schizophrenia,” Journ. Ment. Sci., 85, 1224.CrossRefGoogle Scholar
10 Dynes, J. B. (1939), “Affective Sequelae of Convulsant Drug Therapy,” ibid., 85, 489.Google Scholar
11 Stoddart, W. H. B., Mind and its Disorders. London: Lewis.Google Scholar
12 Henderson, D. K., and Gillespie, R. D. (1936), A Textbook of Psychiatry. Oxford University press.Google Scholar
13 Cook, L. C. (1938), “The Range of Mental Reaction States Influenced by Cardiazol Convulsions,” Journ. Ment. Sci., 85, 664.CrossRefGoogle Scholar
14 Lewis, A. (1935), “Prognosis,” Lancet, 1, 265.Google ScholarPubMed
15 Humbert, F., and Friedemann, A. (1938), “Critique and Indications of treatments in Schizophrenia,” Amer. Journ. Psychiat., 94, 174 (May supplement).CrossRefGoogle Scholar
16 Abse, D. W. (1940), “The Psychology of Convulsion Therapy,” Journ. Ment. Sci., 86, 95.CrossRefGoogle Scholar
17 Speer, J. M. C. (1939), “Some Remarks on Cardiazol Treatment,” ibid., 85, No. 354, Supplement, p. 6.Google Scholar
18 Kuppers, E. (1937), “Die Insulin und Cardiazol Behandlung der Schizophrenie,” Psychiat.-neurolog. Wochenschr., 52, 597.Google Scholar
19 Thomas, W. R., and Wilson, I. G. H. (1938), Report on Cardiazol Treatment and on the Present Application of Hypoglycaemic Shock Treatment of Schizophrenia. H.M. Stationery Office.Google Scholar
20 Meduna, L. Quoted by Thomas, and Wilson, , see ref. (19) Google Scholar
21 Steinfeld, J. Quoted by Thomas, and Wilson, . See ref. (19).Google Scholar
22 Tooth, G., and Blackburn, J. M. (1939), “Disturbance of Memory after Convulsant Treatment,” Lancet, 2, 17.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.
4
Cited by

Save article to Kindle

To save this article to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

The Influence of Cardiazol on Chronic Schizophrenia
Available formats
×

Save article to Dropbox

To save this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about saving content to Dropbox.

The Influence of Cardiazol on Chronic Schizophrenia
Available formats
×

Save article to Google Drive

To save this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you used this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about saving content to Google Drive.

The Influence of Cardiazol on Chronic Schizophrenia
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *